Phase II evaluation of three-day topotecan in recurrent platinum-sensitive ovarian carcinoma: a gynecologic oncology group study.

Miller, David Scott

Phase II evaluation of three-day topotecan in recurrent platinum-sensitive ovarian carcinoma: a gynecologic oncology group study. [electronic resource] - Cancer Oct 2003 - 1664-9 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S.

0008-543X

10.1002/cncr.11690 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Agents--administration & dosage
Female
Humans
Middle Aged
Neoplasm Recurrence, Local--drug therapy
Ovarian Neoplasms--drug therapy
Topotecan--administration & dosage